Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SURGERY PARTNERS, INC.

(SGRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Surgery Partners : Shares Rise After SVB Leerink Initiates Coverage at Outperform

10/18/2021 | 12:35pm EST


© MT Newswires 2021
All news about SURGERY PARTNERS, INC.
11/30Barclays Starts Surgery Partners at Overweight With $73 Price Target
MT
11/30NORTH AMERICAN MORNING BRIEFING : -3-
DJ
11/29Health Care Stocks Hanging On For Narrow Gains Near Monday Close
MT
11/29Health Care Stocks Rising Monday Afternoon
MT
11/29Surgery Partners Shares Rise on Stifel Upgrade
MT
11/29Stifel Upgrades Surgery Partners to Buy From Hold; Price Target is $51
MT
11/22SURGERY PARTNERS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct ..
AQ
11/15Surgery Partners, Inc. Announces Closing of Public Offering of Common Stock and Exercis..
AQ
11/09SURGERY PARTNERS, INC. : Entry into a Material Definitive Agreement, Financial Statements ..
AQ
11/09Surgery Partners, Inc. Announces Pricing of $279.0 million Public Offering of Common St..
AQ
More news
Analyst Recommendations on SURGERY PARTNERS, INC.
More recommendations
Financials (USD)
Sales 2021 2 236 M - -
Net income 2021 -56,0 M - -
Net Debt 2021 2 540 M - -
P/E ratio 2021 -58,8x
Yield 2021 -
Capitalization 4 053 M 4 053 M -
EV / Sales 2021 2,95x
EV / Sales 2022 2,71x
Nbr of Employees 9 950
Free-Float 38,7%
Chart SURGERY PARTNERS, INC.
Duration : Period :
Surgery Partners, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SURGERY PARTNERS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 46,11 $
Average target price 63,00 $
Spread / Average Target 36,6%
EPS Revisions
Managers and Directors
J. Eric Evans Chief Executive Officer & Director
Thomas F. Cowhey CFO, Principal Accounting Officer & Executive VP
Wayne S. DeVeydt Executive Chairman
Varun Gadhok Chief Information Officer & Senior Vice President
Roxanne Womack Chief Compliance Officer & Senior Vice President
Sector and Competitors